Adhesion molecules before and after propylthiouracil in patients with subclinical hyperthyroidism

Area of Science:

• Endocrinology
• Cardiovascular Research
• Molecular Biology

Background:

• Subclinical hyperthyroidism is associated with increased cardiovascular risk.
• Adhesion molecules play a role in atherosclerosis and inflammation.
• The impact of treatment on these markers is not fully understood.

Purpose of the Study:

• To evaluate the effect of propylthiouracil on adhesion molecules (sICAM-1, sVCAM-1, sE-Selectin) in subclinical hyperthyroidism.
• To compare post-treatment levels with healthy controls.

Main Methods:

• 168 patients with subclinical hyperthyroidism received propylthiouracil for one year.
• Adhesion molecule levels were measured pre- and post-treatment.
• Comparison with 148 healthy controls receiving placebo.

Main Results:

• Soluble intercellular adhesion molecule-1 (sICAM-1) was significantly higher in patients than controls and decreased post-treatment.
• Soluble vascular cell adhesion molecule-1 (sVCAM-1) showed no significant change.
• Soluble E-selectin (sE-Selectin) levels increased post-treatment, though not statistically significant compared to baseline.

Conclusions:

• Propylthiouracil effectively reduced sICAM-1 in subclinical hyperthyroidism patients.
• Further research is needed to mitigate atherosclerosis and cancer risks.
• Treatment did not normalize sICAM-1 levels to those of healthy individuals.